Uncategorized | NexPlasmaGen

-1

archive,category,category-uncategorized,category-1,bridge-core-2.6.4,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-theme-ver-24.9,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,qode-wpml-enabled,wpb-js-composer js-comp-ver-7.7,vc_responsive

Uncategorized

25 Apr Clinical trials protocol published in BMC Cancer journal

Posted at 15:35h in Uncategorized 0 Comments

0 Likes

Montreal / April 25, 2025 – Clinical researchers at the University of Montreal Hospital Center (CHUM) have published in the journal BMC Cancer the clinical protocol for human safety trials initiated at CHUM with NexPlasmaGen medical technology for the treatment of breast cancer. The published article can...

06 Oct NexPlasmaGen’s new funding for R&D and commercialization

Posted at 17:49h in Uncategorized 1 Comment

0 Likes

Montreal / October 06, 2023 - NexPlasmaGen received a financial support of $219,500 from Quebec's Ministère de l'économie, de l'innovation et de l'énergie (MEIE), the National Research Council of Canada (NRC), the Université de Montréal (UdM) and the Mouvement des accélérateurs d'innovation du Québec (MAIN)...

Uncategorized

25 Apr Clinical trials protocol published in BMC Cancer journal

06 Oct NexPlasmaGen’s new funding for R&D and commercialization

London, UK Offices